03 September 2010
Agilent Technologies Ships Milestone 300th, 301st X-Ray Crystallography Systems
SANTA CLARA, Calif., September 1, 2010 – Agilent Technologies, Inc. (NYSE: A) today announced that it has shipped the 300th and 301st X-ray crystallography systems manufactured by Oxford Diffraction Limited, part of Varian, Inc. which was acquired by Agilent in May, 2010.
> MORE INFO
17 May 2010
Agilent Technologies Completes Acquisition of Varian, Inc
Agilent Technologies Inc. (NYSE: A) today announced that its acquisition of scientific-equipment maker Varian, Inc. is now final...
> MORE INFO
18 December 2009
Oxford Diffraction holds second annual EU User Meeting
Oxford Diffraction recently held its annual EU user meeting at its UK headquarters in Yarnton, Oxford...
> MORE INFO
08 December 2008
Oxford Diffraction hold Europe Region Small Molecule User Meeting
To coincide with the opening of our new UK demonstration facilities and the recent launch of the SuperNova product, Oxford Diffraction will be hosting a Europe region user meeting during the 8th and 9th December.
> MORE INFO
18 November 2008
Oxford Diffraction builds on User Community with launch of User Forum
Oxford Diffraction have designed a web based user forum to provide their global users with a resource for the exchange of ideas and tips relating to their X-ray diffraction systems, and to encourage scientific collaborations and crystallographic discussion.
> MORE INFO
24 August 2008
New Dual Wavelength X-ray Diffractometer from Oxford Diffraction, now a part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
Oxford, UK - Oxford Diffraction, Now a part of Varian, Inc. (NasdaqGS: VARI) introduced its new dual wavelength X-ray diffractometer for the analysis of small molecules and proteins. The SuperNova is the first dual wavelength diffraction system to use entirely high intensity micro-source X-ray technology. It includes innovations in both X-ray technology and data analysis, enabling faster results even for the most challenging crystals.
> MORE INFO
30 March 2007
King's College London to invest in state-of-the-art equipment for structural biology
The Randall Division of Cell and Molecular Biophysics at King's College London have confirmed their investment in an Oxford Diffraction PX Scanner and an Xcalibur Nova system.
> MORE INFO
11 July 2007
'LIVE' PX SCANNER DEMO AT ACA BOOTH 203
Oxford Diffraction continues to innovate and push the boundaries in everything we do. This time we're running a 'Live' demo of our in situ X-ray diffraction product PX Scanner. From the 21st July until the 25th, we'll have a 'working' PX Scanner on our exhibition booth no. 203 at the American Crystallographic Association (ACA) annual meeting in Salt Lake City, Utah.
> MORE INFO
23 August 2007
Ultimate quality X-ray data from ATLAS - the fastest commercially available CCD detector
The all new Atlas CCD detector from Oxford Diffraction is the ideal detector for high speed, high resolution data collections on small molecules. As the fastest commercially available CCD detector the Atlas is up to 3.5 times faster than other CCD detectors.
> MORE INFO
09 November 2007
Max Plank Institute celebrate opening of a state-of-the-art Protein Structural Biology Laboratory.
Guests from the Martinsried Max Planck Institutes mingled with structural biologists from the nearby research centres in both Munich (Gene Center, Technical University and GSF) and T-bingen, as well as with representatives of local companies from the Martinsried Biotech campus.
> MORE INFO
07 April 2008
Varian, Inc. Acquires Oxford Diffraction, Ltd.
Palo Alto, CA - Varian, Inc. (NasdaqGS: VARI) announced today that it has acquired Oxford Diffraction, Ltd., a privately owned company based in Abingdon, U.K. Oxford Diffraction is a leader in x-ray crystallography, an analytical technique used by scientists in pharmaceutical research and other research laboratories to determine the structure of both small molecules and large molecules such as proteins.
> MORE INFO
30 March 2009
$21.5 billion Extra for US Science through American Recovery and Re-investment Act (ARRA) 2009
Following the announcement of the $787 billion funding package by President Obama, these key facts relate to the allocation for scientific research...
> MORE INFO